COVID-19 Health Evidence Summary No.37 by Millington, Kerry & Reddin, Samantha
   
1 
Evidence Summary 
y 
 
 
COVID-19  
Health Evidence Summary No.37 
Kerry Millington & Samantha Reddin 
Liverpool School of Tropical Medicine (LSTM) & Institute of Development Studies 
13 May 2020  
 
This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
08.05.2020 Clinical 
findings of 
patients with 
coronavirus 
disease 2019 
in Jiangsu 
province, 
China: A 
retrospective, 
multi-center 
study 
PLOS 
Neglected 
tropical 
diseases | 
Research 
article  
 Study aims to describe the clinical 
characteristics of COVID-19 and 
identify the risk factors for severe 
illness of COVID-19 in Jiangsu 
province, China. 
 In this case series in Jiangsu 
Province, COVID-19 patients had 
less severe symptoms and had 
better outcomes than the initial 
COVID-19 patients in Wuhan.  
 The BMI ≥ 28 kg/m2 and a known 
history of type 2 diabetes were 
independent risk factors of severe 
illness in patients with COVID-19. 
  
2 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
12.05.2020 Early 
estimates 
of the 
indirect 
effects of 
the COVID-
19 
pandemic 
on 
maternal 
and child 
mortality in 
low-income 
and 
middle-
income 
countries: a 
modelling 
study 
The Lancet 
Global Health 
| Article 
 Study, estimates the additional 
maternal and under-5 child deaths 
resulting from the potential 
disruption of health systems and 
decreased access to food. 
 Least severe scenario (coverage 
reductions of 9·8–18·5% and 
wasting increase of 10%) over 6 
months would result in 253 500 
additional child deaths and 12 200 
additional maternal deaths.  
 Most severe scenario (coverage 
reductions of 39·3–51·9% and 
wasting increase of 50%) over 6 
months would result in 1 157 000 
additional child deaths and 56 700 
additional maternal deaths. 
12.05.2020 Time-to-
Death 
approach 
in revealing 
Chronicity 
and 
Severity of 
COVID-19 
across the 
World 
PLoS ONE 
|Article 
 Study aims to predict the impact of 
duration of exposure to COVID-19 
on the mortality rates increment.  
 COVID-19 infected top seven 
countries, Germany, China, France, 
United Kingdom, Iran, Italy and 
Spain, and World as a whole, were 
used for modeling.  
 The study adds information about 
the quantum of the severity and time 
elapsed to death to help the 
Government  take necessary and 
appropriate steps to control this 
pandemic. 
11.05.2020 Short-term 
forecasts of 
healthcare 
demand for 
countries in 
the early 
stage of 
MRC Centre 
for Global 
Infectious 
Disease 
Analysis, 
Imperial 
Short-term forecasts of healthcare demand for 
low- & middle-income countries showing: 
 Number of #COVID19 infections 
 Expected number of deaths next 14 
days 
 Number of people requiring critical 
care 
3 
COVID-19 
epidemics 
College 
London 
 Impact of policy change 
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
11.05.2020 The SARS-
CoV-2 
Epidemic in 
Zimbabwe: 
Quo Vadis? 
Clinical 
Infectious 
Diseases 
|  Accepted 
manuscript 
 We use the situation in Zimbabwe 
to build an argument that the 
epidemic is likely to be attenuated in 
some countries with similar socio-
economic and cultural structures.  
 However, even an attenuated 
epidemic may overwhelm weak 
health systems, emphasising the 
importance of prevention. These 
prevention strategies should be 
tailored to the unique social and 
cultural networks of individual 
countries which may facilitate the 
spread of SARS-CoV 2.  
 It is also equally important to 
maintain services for the major 
infectious diseases in the region 
such as tuberculosis and malaria. 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
12.05.2020 Africa faces difficult choices in 
responding to COVID-19 
Lancet | 
Correspondence 
Titus Divala 
Rachael M Burke 
Latif Ndeketa 
Elizabeth L Corbett 
Peter MacPherson 
12.05.20 COVID-19 and Racial/Ethnic 
Disparities 
JAMA | Viewpoint Monica Webb 
Hooper, Anna 
María Nápoles,; 
4 
Eliseo J. Pérez-
Stable,  
12.05.2020 Patients in Pakistan are actively 
participating in relief activities 
during the covid-19 pandemic 
BMJ | Opinion Hussain Jafri 
06.05.2020 Current efforts and challenges 
facing responses to 2019-nCoV in 
Africa 
Glob Health res Policy 
| Commentary 
Don Eliseo Lucero-
Prisno et al.  
11.05.2020 Clinical Trials for COVID-19 
should include sex as a variable 
J Clin Invest | 
Viewpoint 
Evelyne Bischof, 
Jeannette Wolfe & 
Sabra L Klein 
10.05.2020 Pandemics are social 
phenomena demanding breadth 
of expertise 
Wonkhe Melissa Leach 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence 
& policy 
maps 
Current 
research 
including trials 
  Diagnosti
cs 
  Treatment
s 
  Vaccin
es 
WHO 
sitreps 
WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-
CoV-2 Test 
Tracker 
  Global 
COVID-19 
Clinical 
Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Argumen
ts 
Indonesi
a 
EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-
CoV-2 
Diagnostic
s: 
performanc
e data 
  US NIH 
registered 
clinical 
trials 
Vaccine 
Centre 
LSHTM 
5 
Johns 
Hopkins 
University 
Europea
n CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based 
tests for 
COVID-19 
  Solidarity 
trial 
  
WEF 
  Sierra 
Leone 
 Oxford 
C19 
Governme
nt 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: 
C19 
Testing 
  COVID-
19 
Therapeuti
cs 
Accelerator 
  
Our World 
in Data 
  Singapor
e 
 Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 
5050 
  UK   Cochrane       
CEBM, 
University 
of Oxford 
  US   Clinicaltrials.g
ov 
      
Humanitari
an Data 
Exchange 
       UKCDR       
Information 
is Beautiful 
              
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
6 
C19 Resource Hubs 
Global  Region
al & 
Country 
Academi
c journals 
& 
Publisher
s 
Global Health 
Institutes/Centres/Funders/O
ther 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa 
CDC 
The 
Lancet 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communicatio
n 
African 
Union 
NEJM LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Elsevier ICL MRC Centre for Global 
Infectious Disease Analysis  
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll
: SSA 
BMJ ODI SLH: 
Handwashi
ng in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Response 
Fund 
Global 
Health 
Network 
Africa 
Cell 
Press 
Johns Hopkins University 
 
  Rings 
HSG 
Resyst 
Reach 
Wellcome 
UN African 
Academ
y of 
Science
s 
Cochran
e 
resource
s 
Center for Global 
Development 
    Social 
Developme
nt Direct 
C19 blog 
series 
UN Women Africa 
Evidenc
e 
Network 
PLoS CMMID Repository     
7 
UNOCHA   Annals of 
Internal 
Medicine 
Norwegian Institute of Public 
Health 
    
UNHCR    Wiley 
Health 
Economi
cs 
Oxford Centre for Evidence-
based Medicine 
    
UNICEF    Pre-
prints 
medRxiv 
and 
bioRxiv 
 HEART     
UNESCO   SAGE 
journals 
 UKRI     
UN WFP   
 
 Evidence Aid     
GOARN      NIH     
EPI-WIN           
World Bank           
Our World in 
Data 
          
COVID-19 
Narratives by 
David 
Nabarro 
          
Reliefweb           
Humanitarian 
OpenStreetM
ap Team 
          
Global 
Partnership 
          
8 
for 
Sustainable 
Development 
Data 
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app  WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
9 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
FutureLearn University 
of Edinburgh & Royal 
10 
weekly 
study 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
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